Pharmaceutical company Astellas reported on Tuesday the promotion of Geoff Towle to vice president of Oncology Marketing at Astellas US.
In the escalated role, Towle will be responsible for building Astellas Oncology brands with customers in large and specialty market segments through the development and implementation of innovative marketing methods, reporting to senior vice president of Oncology Business Unit, Mark Reisenauer.
Most recently, Towle was employed as senior director, Oncology Marketing at Astellas, where he led the development of brand strategies, messaging and tactics for XTANDI as well as led four best-in-class launches within Astellas and across the industry based on speed of execution, quality and performance.
At the start of his career, Towle has served in a variety of positions with increasing responsibility at Abbott Laboratories Inc (now AbbVie).
Natera submits Signatera CDx PMA to FDA for bladder cancer use
Astrazeneca Imfinzi perioperative regimen gains positive EU CHMP opinion in early gastric cancer
I Peace generates human iPS cells from NKT cells and offers them for research use
Frontage expands early phase clinical research capabilities across US and China
Summit Therapeutics' BLA for ivonescimab in EGFR-mutated NSCLC accepted by FDA
InSysBio agrees new collaborative project with BeOne Medicines
Physiomics secures new modelling contract with Numab Therapeutics
Mabwell reports first patient dosed with 7MW4911 in US trial
Atossa Therapeutics' founder and CEO named one of The Top 50 Healthcare Technology CEOs of 2025
Avacta secures FDA clearance for second pre|CISION oncology programme
Guardant Health and Merck enter multi-year oncology diagnostics collaboration
Akeso secures NMPA review acceptance for gumokimab in ankylosing spondylitis